Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Brief Report February 28 2025
The bone marrow NK cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy
Review Article February 28 2025
Exploring the thrombus niche: Lessons learned and potential therapeutic opportunities
Review Article February 28 2025
The Future of Follicular Lymphoma Management: Strategies on the Horizon
Review Article February 28 2025
End points and Outcomes in Follicular Lymphoma: What should we measure, how, and why?
Research Article February 27 2025
Decoding functional hematopoietic progenitor cells in the adult human lung
Research Article February 26 2025
Novel Regulators of GVHD Revealed Through Microbiome and Metabolome Patterns Across Distinct Intestinal Regions.
Research Article February 26 2025
Integrated cross-linking by TG2 and FXIII generates hepatoprotective fibrin(ogen) deposits in injured liver
Research Article February 26 2025
Histo-blood group ABO system transferase plasma levels and risk of future venous thromboembolism: The HUNT Study
Research Article February 26 2025
Ibrutinib Lead-in followed by Venetoclax Plus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia - SAKK 34/17
Research Article February 26 2025
STING activation improves T-cell-engaging immunotherapy for acute myeloid leukemia
Research Article February 26 2025
Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph− B-lineage ALL: the GIMEMA LAL2317 Phase 2 Study
Research Article February 26 2025
A CEBPB/IL-1β/TNF-α Feedback Loop Drives Drug Resistance to Venetoclax and MDM2 Inhibitors in Monocytic Leukemia
Research Article February 26 2025
The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL
Research Article February 26 2025
Synergistic antitumor effect of combined EZH2 and DOT1L inhibition in B-cell lymphoma
Research Article February 26 2025
NOTCH1 dimeric signaling is essential for T-cell leukemogenesis and leukemia maintenance
Research Article February 26 2025
cMPL-Based Purification and Depletion of Human Hematopoietic Stem Cells: Implications for Pretransplant Conditioning
Research Article February 26 2025
Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma
Research Article February 26 2025
A First-in-Class JAK/ROCK Inhibitor, Rovadicitinib, for Glucocorticoid-Refractory or -Dependent Chronic GVHD
Research Article February 26 2025
Magrolimab plus azacitidine vs physician's choice for untreated TP53-mutated acute myeloid leukemia: the ENHANCE-2 study
Research Article February 26 2025
Venetoclax and Decitabine vs Intensive Chemotherapy as Induction for Young Patients with Newly Diagnosed AML
Research Article February 26 2025
Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance post ASCT in myeloma
Research Article February 20 2025
Defining pathogenic IL-17 and CSF-1 gene expression signatures in chronic graft-versus-host disease
Research Article February 20 2025
Surface pTα expression predicts LCK activation and preclinical synergy of LCK and JAK coinhibition in adult T-ALL
Review Article February 19 2025
How I treat patients who are refractory to platelet transfusions
Review Article February 19 2025
Clinical-genomic profiling of MDS to inform allo-HSCT:Recommendations from an international panel on behalf of the EBMT
Review Article February 19 2025
Immunoactinopathies revisited: Understanding clinical manifestations and biological pathways
Review Article February 12 2025
Emerging biomarkers for CD3×CD20 bispecific antibodies in lymphoma
Discussion February 12 2025
The United Kingdom Infected Blood Inquiry: Its findings and lessons for the future of transfusion
Research Article February 12 2025
Outcomes Among Adult Recipients of CAR T-cell Therapy for Burkitt Lymphoma
Research Article February 12 2025
Three-year follow-up analysis of first-line axicabtagene ciloleucel in high-risk large B-cell lymphoma (ZUMA-12)
Research Article February 10 2025
17(R)-RESOLVIN D1 PROTECTS AGAINST SICKLE CELL-RELATED INFLAMMATORY CARDIOMYOPATHY IN HUMANIZED MICE
Research Article February 10 2025
N-homocysteinylation of β-arrestins biases GPCR signaling and promotes platelet activation
Research Article February 7 2025
Targeting cell surface VISTA expression on allospecific naïve T cells promotes tolerance
Brief Report February 7 2025
Venetoclax plus Daunorubicin and Cytarabine for Newly Diagnosed Acute Myeloid Leukemia: Results of a Phase 1b Study
Brief Report February 7 2025
The JAK2 46/1 haplotype influences PD-L1 expression.
Research Article February 6 2025
Targeting Caseinolytic Mitochondrial Matrix Peptidase, a Novel Contributor to High-risk Behavior, in Multiple Myeloma
Review Article February 6 2025
Impact of new medications on the treatment of Immune TTP
Letter February 5 2025
X-linked sideroblastic anemia in females
Review Article February 5 2025
EMZL at various sites: learning from each other
Research Article February 5 2025
PSTK inhibition activates cGAS-STING, precipitating ferroptotic cell death in leukemic stem cells
Research Article February 3 2025
Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD
Research Article February 3 2025
Reactive oxygen species regulate early development of the intestinal macrophage-microbiome interface
Research Article February 3 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy
Review Article February 3 2025
How I approach pharmacological thromboprophylaxis in children
Review Article January 30 2025
Sickle Cell Trait Does Not Cause "Sickle Cell Crisis" Leading to Exertion-Related Death: A Systematic Review
Research Article January 30 2025
MRD-guided zanubrutinib, venetoclax and obinutuzumab in relapsed CLL: primary endpoint analysis from the CLL2-BZAG trial
Research Article January 27 2025
Protection of β2GPI-Deficient Mice from Thrombosis Reflects a Defect in PAR3-facilitated Platelet Activation
Review Article January 27 2025
Platelet activation and signaling in thrombus formation
Review Article January 27 2025
Factor XIII: Driving (Cross-)Links in Hemostasis, Thrombosis, and Disease
Research Article January 27 2025
Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response
Page 1 of 3
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals